^
+ Follow VILDAGLIPTIN EXPERIENCE COMPARED TO Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 719781
                    [Title] => Drug significantly cuts  hypoglycemic events
                    [Summary] => 

A newly published study showed that the Novartis oral diabetes medication vildagliptin, when taken with metformin, caused no hypoglycemia, was well adhered to and improved blood sugar levels in South Asian patients with type 2 diabetes mellitus (T2DM) fasting during daylight hours for Ramadan.

[DatePublished] => 2011-08-25 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
VILDAGLIPTIN EXPERIENCE COMPARED TO
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 719781
                    [Title] => Drug significantly cuts  hypoglycemic events
                    [Summary] => 

A newly published study showed that the Novartis oral diabetes medication vildagliptin, when taken with metformin, caused no hypoglycemia, was well adhered to and improved blood sugar levels in South Asian patients with type 2 diabetes mellitus (T2DM) fasting during daylight hours for Ramadan.

[DatePublished] => 2011-08-25 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with